Cargando…
To Die or to Survive, a Fatal Question for the Destiny of Prostate Cancer Cells after Androgen Deprivation Therapy
Prostate cancer is the most frequently diagnosed non-skin cancer in adult males in North America and is the second leading cause of cancer-related mortality. For locally advanced or metastatic disease, androgen deprivation, through medical or surgical castration, is the primary treatment to induce p...
Autores principales: | Zhang, Kai-Xin, Firus, Jessica, Prieur, Brenda, Jia, William, Rennie, Paul S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757374/ https://www.ncbi.nlm.nih.gov/pubmed/24212771 http://dx.doi.org/10.3390/cancers3021498 |
Ejemplares similares
-
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question
por: Caramella, Irene, et al.
Publicado: (2022) -
Destiny
Publicado: (1892) -
Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003) -
The destinies of the stars
por: Arrhenius, Svante
Publicado: (2019) -
Colliding with destiny
Publicado: (2008)